| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Danielle K Maue, Daniel T Cater, Colin M Rogerson, Aimee Ealy, Alvaro J Tori, Samer Abu-Sultane. Outcomes of a respiratory therapist driven high flow nasal cannula management protocol for pediatric critical asthma patients. Pediatric pulmonology. 2023-08-22. PMID:37606224. |
this study aimed to determine if a respiratory therapist (rt)-driven high flow nasal cannula (hfnc) protocol could decrease duration of hfnc use, pediatric intensive care unit (picu) and hospital length of stay (los), and duration of continuous albuterol use in pediatric patients with critical asthma. |
2023-08-22 |
2023-09-07 |
Not clear |
| Dariusz Madajczak, Thierry Daboval, Ryszard Lauterbach, Beata Łoniewska, Witold Błaż, Tomasz Szczapa, Iwona Sadowska-Krawczenko, Marzena Michalak-Kloc, Helena Sławska, Maria Borszewska-Kornacka, Renata Bokinie. Protocol for a multicenter, double-blind, randomized, placebo-controlled phase III trial of the inhaled β2-adrenergic receptor agonist salbutamol for transient tachypnea of the newborn (the REFSAL trial). Frontiers in pediatrics. vol 10. 2023-01-30. PMID:36714639. |
this study aims to evaluate the efficacy and safety of salbutamol as supportive pharmacotherapy together with non-invasive nasal continuous positive airway pressure (niv/ncpap) for the prevention of persistent pulmonary hypertension of the newborn (pphn) in infants with ttn. |
2023-01-30 |
2023-08-14 |
Not clear |
| Ariel Berlinski, Joshua Spiv. In Vitro Characterization of Aerosolized Albuterol Generated by a Jet Nebulizer and Delivered through a Heated Flow Nasal Cannula System. Pharmaceuticals (Basel, Switzerland). vol 15. issue 10. 2022-10-27. PMID:36297393. |
in vitro characterization of aerosolized albuterol generated by a jet nebulizer and delivered through a heated flow nasal cannula system. |
2022-10-27 |
2023-08-14 |
Not clear |
| Kelsey R Anderson, Natalie Villafranco, Lindsay Hatzenbuehler Cameron, Erica K Schallert, Ashley Joshi-Patel, Amy Arrington, Andrea Dea. A 16-Year-Old Boy With Cough and Fever in the Era of COVID-19. Pediatrics. vol 147. issue 1. 2021-01-13. PMID:32788269. |
he showed initial improvement for 48 hours with antibiotics, intravenous fluid resuscitation, oxygen via nasal cannula, albuterol, and prednisone. |
2021-01-13 |
2023-08-13 |
dog |
| Maohua Liu, Jingxiu Zhang, Chengjun Li. Clinical efficacy of recombinant human latrophilin 3 antibody in the treatment of pediatric asthma. Experimental and therapeutic medicine. vol 15. issue 1. 2020-09-30. PMID:29375702. |
a total of 342 pediatric asthma cases were recruited and randomly divided into three groups, receiving treatment with rhlphn3 ab (n=134), salbutamol (n=108) or montelukast (n=100) by nasal aerosolization. |
2020-09-30 |
2023-08-13 |
human |
| Jie Li, Wu Wei, James B Fin. In vitro comparison of unit dose vs infusion pump administration of albuterol via high-flow nasal cannula in toddlers. Pediatric pulmonology. vol 55. issue 2. 2020-09-03. PMID:31782914. |
in vitro comparison of unit dose vs infusion pump administration of albuterol via high-flow nasal cannula in toddlers. |
2020-09-03 |
2023-08-13 |
Not clear |
| Ahsan F Bairam, Mohammed I Rasool, Fatemah A Alherz, Maryam S Abunnaja, Amal A El Daibani, Saud A Gohal, Eid S Alatwi, Katsuhisa Kurogi, Ming-Cheh Li. Impact of SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of phenylephrine and salbutamol by human SULT1A3 allozymes. Pharmacogenetics and genomics. vol 29. issue 5. 2020-03-09. PMID:31145702. |
phenylephrine and salbutamol are drugs that are used widely to treat diseases/disorders, such as nasal congestion, hypotension, and asthma, in individuals of different age groups. |
2020-03-09 |
2023-08-13 |
human |
| Laura Kwiatkowski, Jessica Mitchell, Jeffrey Langlan. Resolution of Allergic Rhinitis and Reactive Bronchospasm With Supplements and Food-specific Immunoglobulin G Elimination: A Case Report. Alternative therapies in health and medicine. vol 22. issue S3. 2018-09-17. PMID:27866183. |
the bronchospasm severity was based on the frequency of a sensation of wheezing and chest tightness, the frequency of inhaler use, and the occurrence of any exacerbation of symptoms with acute respiratory illness results • after 1 mo, in which the patient used the natural supplements, she experienced a 90% improvement in coughing; a 70% improvement in nasal congestion; less chest tightness; and no need for use of loratadine, diphenhydramine, or albuterol. |
2018-09-17 |
2023-08-13 |
human |
| Lodewijk A W Vijftigschild, Gitte Berkers, Johanna F Dekkers, Domenique D Zomer-van Ommen, Elizabeth Matthes, Evelien Kruisselbrink, Annelotte Vonk, Chantal E Hensen, Sabine Heida-Michel, Margot Geerdink, Hettie M Janssens, Eduard A van de Graaf, Inez Bronsveld, Karin M de Winter-de Groot, Christof J Majoor, Harry G M Heijerman, Hugo R de Jonge, John W Hanrahan, Cornelis K van der Ent, Jeffrey M Beekma. β2-Adrenergic receptor agonists activate CFTR in intestinal organoids and subjects with cystic fibrosis. The European respiratory journal. vol 48. issue 3. 2018-04-05. PMID:27471203. |
10 subjects with a r117h or a455e mutation were included and showed changes in the nasal potential difference measurement after treatment with oral salbutamol, including a significant improvement of the baseline potential difference of the nasal mucosa (+6.35 mv, p<0.05), suggesting that this treatment might be effective in vivo furthermore, plasma that was collected after oral salbutamol treatment induced cftr activation when administered ex vivo to organoids.this proof-of-concept study suggests that organoids can be used to identify drugs that activate cftr function in vivo and to select route of administration. |
2018-04-05 |
2023-08-13 |
human |
| Sneha R Salunke, Sanjay B Pati. Ion activated in situ gel of gellan gum containing salbutamol sulphate for nasal administration. International journal of biological macromolecules. vol 87. 2016-12-15. PMID:26899173. |
ion activated in situ gel of gellan gum containing salbutamol sulphate for nasal administration. |
2016-12-15 |
2023-08-13 |
Not clear |
| Sneha R Salunke, Sanjay B Pati. Ion activated in situ gel of gellan gum containing salbutamol sulphate for nasal administration. International journal of biological macromolecules. vol 87. 2016-12-15. PMID:26899173. |
the main aim of present study was to develop a novel mucoadhesive in situ gel of salbutamol sulphate using gellan gum and hydroxylpropyl methyl cellulose (hpmc) for nasal administration. |
2016-12-15 |
2023-08-13 |
Not clear |
| Sneha R Salunke, Sanjay B Pati. Ion activated in situ gel of gellan gum containing salbutamol sulphate for nasal administration. International journal of biological macromolecules. vol 87. 2016-12-15. PMID:26899173. |
hence, in situ gel system of gellan gum may be a promising approach for nasal delivery of salbutamol sulphate for therapeutic improvement. |
2016-12-15 |
2023-08-13 |
Not clear |
| Sarah A Perry, Kenneth C Kesser, David E Geller, Dawn M Selhorst, John K Rendle, James H Hertzo. Influences of cannula size and flow rate on aerosol drug delivery through the Vapotherm humidified high-flow nasal cannula system. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. vol 14. issue 5. 2014-03-14. PMID:23628834. |
we investigated the in vitro inspired dose and particle size distribution of albuterol delivered by a vibrating mesh nebulizer through the vapotherm (stevensville, md) humidified high-flow nasal cannula system. |
2014-03-14 |
2023-08-12 |
Not clear |
| Ragwa M Farid, Mohamed A Etman, Aly H Nada, Abd El Azeem R Ebia. Formulation and in vitro evaluation of salbutamol sulphate in situ gelling nasal inserts. AAPS PharmSciTech. vol 14. issue 2. 2013-10-17. PMID:23516112. |
formulation and in vitro evaluation of salbutamol sulphate in situ gelling nasal inserts. |
2013-10-17 |
2023-08-12 |
Not clear |
| Ragwa M Farid, Mohamed A Etman, Aly H Nada, Abd El Azeem R Ebia. Formulation and in vitro evaluation of salbutamol sulphate in situ gelling nasal inserts. AAPS PharmSciTech. vol 14. issue 2. 2013-10-17. PMID:23516112. |
the aim of this study was to formulate salbutamol sulfate (ss), a model drug, as mucoadhesive in situ gelling inserts having a high potential as nasal drug delivery system bypassing the first-pass metabolism. |
2013-10-17 |
2023-08-12 |
Not clear |
| Arzu Ari, Robert Harwood, Meryl Sheard, Patricia Dailey, James B Fin. In vitro comparison of heliox and oxygen in aerosol delivery using pediatric high flow nasal cannula. Pediatric pulmonology. vol 46. issue 8. 2011-11-21. PMID:21438178. |
drug administration via high flow nasal cannula (hfnc) has been described in pediatrics but the amount of albuterol delivery with an hfnc is not known. |
2011-11-21 |
2023-08-12 |
Not clear |
| Gajanan B Kasawar, Mazahar Farooqu. Development and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution. Journal of pharmaceutical and biomedical analysis. vol 52. issue 1. 2010-04-08. PMID:20045275. |
development and validation of a stability indicating rp-hplc method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution. |
2010-04-08 |
2023-08-12 |
Not clear |
| Concepcion F Estivariz, Lubna I Bhatti, Ritu Pati, Bette Jensen, Matthew J Arduino, Daniel Jernigan, John J Lipuma, Arjun Srinivasa. An outbreak of Burkholderia cepacia associated with contamination of albuterol and nasal spray. Chest. vol 130. issue 5. 2006-12-14. PMID:17099009. |
an outbreak of burkholderia cepacia associated with contamination of albuterol and nasal spray. |
2006-12-14 |
2023-08-12 |
Not clear |
| C Russo, D Zeng, G Prosperini, L Spicuzza, F Guarino, R Polos. Effect of salbutamol on nasal symptoms and mast cell degranulation induced by adenosine 5' monophosphate nasal challenge. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. vol 35. issue 9. 2006-01-17. PMID:16164447. |
effect of salbutamol on nasal symptoms and mast cell degranulation induced by adenosine 5' monophosphate nasal challenge. |
2006-01-17 |
2023-08-12 |
Not clear |
| Anwar A Hussain, Adnan Dakkuri, Yih-Loong Lai, Ashraf Traboulsi, Munir A Hussai. Nasal administration of albuterol: an alternative route of delivery. The Journal of pharmacy and pharmacology. vol 56. issue 10. 2005-03-29. PMID:15482634. |
nasal administration of albuterol: an alternative route of delivery. |
2005-03-29 |
2023-08-12 |
Not clear |